Saseedharan S, Aneja P, Chowti A, Debnath K, Mehta KD, Sonone P. Efficacy and safety of intravenous and/or oral levonadifloxacin in the management of secondary bacterial pulmonary infections in COVID-19 patients: findings of a retrospective, real-world, multi-center study. Int J Res Med Sci [Internet]. 2021 Sep. 28 [cited 2024 Apr. 28];9(10):2933-9. Available from: https://www.msjonline.org/index.php/ijrms/article/view/10146